Lawrence Kenyon
Financieel Directeur/CFO bij OUTLOOK THERAPEUTICS, INC.
Vermogen: 7 748 $ op 30-04-2024
Actieve functies van Lawrence Kenyon
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
OUTLOOK THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 15-09-2015 | - |
Directeur/Bestuurslid | 02-08-2018 | - | |
Financieel Directeur/CFO | 18-06-2018 | - | |
Investor Relations Contact | 15-09-2015 | - | |
Bedrijfssecretaris | - | - | |
Treasurer | - | - | |
Algemeen Directeur | 18-06-2018 | 07-07-2021 | |
President | 02-08-2018 | 07-07-2021 |
Loopbaan van Lawrence Kenyon
Eerdere bekende functies van Lawrence Kenyon
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ARNO THERAPEUTICS, INC. | Operationeel Directeur | 18-07-2014 | 01-09-2015 |
Financieel Directeur/CFO | 24-02-2014 | 01-09-2015 | |
Investor Relations Contact | 24-02-2014 | 01-09-2015 | |
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Algemeen Directeur | 23-12-2011 | 31-03-2013 |
Financieel Directeur/CFO | 23-12-2011 | 18-02-2013 | |
President | 23-12-2011 | 31-03-2013 | |
Bedrijfssecretaris | 23-12-2011 | 31-03-2013 | |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Financieel Directeur/CFO | 01-12-2008 | 01-07-2010 |
PAR PHARMACEUTICAL COMPANIES, INC. | Financieel Directeur/CFO | 12-12-2008 | 04-06-2010 |
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Directeur/Bestuurslid | 01-02-2009 | 01-04-2009 |
Operationeel Directeur | - | - | |
Financieel Directeur/CFO | 16-01-2007 | 01-02-2009 | |
President | - | - | |
Bedrijfssecretaris | 16-01-2007 | 01-02-2009 | |
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | Financieel Directeur/CFO | 01-09-2000 | 01-08-2006 |
Bedrijfssecretaris | 01-09-2000 | 01-08-2006 |
Opleiding van Lawrence Kenyon
University of Wisconsin | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
Operationeel
Director of Finance/CFO | 7 |
Corporate Secretary | 4 |
President | 3 |
Sectoraal
Health Technology | 7 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
ARNO THERAPEUTICS, INC. | Health Technology |
OUTLOOK THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
NeoPharm, Inc.
NeoPharm, Inc. BiotechnologyHealth Technology NeoPharm, Inc. engages in the research, development, and commercialization of drugs for the treatment of various cancers and other diseases. The company has built its drug development program around two proprietary technology platforms, a tumor-targeting toxin platform which includes development for a new indication of Pulmonary Fibrosis, and a novel NeoLipid liposomal drug delivery system. It has advanced five drug product candidates in various stages of clinical and pre clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis and asthma. NeoPharm was founded in May 15, 1900and is headquartered in Lake Bluff, IL. | Health Technology |
Endo Generics Holdings, Inc.
Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Health Technology |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Health Technology |
- Beurs
- Insiders
- Lawrence Kenyon
- Ervaring